The Institute of Cancer Research (ICR) is one of the world’s most influential cancer research institutes. Our mission is to make the discoveries that defeat cancer. We have a long and distinguished history of research with a major impact on the outcome for cancer patients. Our unique partnership with The Royal Marsden NHS Foundation Trust (RMH) makes us the largest comprehensive cancer centre in Europe, performing high quality original basic research and translational studies. The ICR was ranked as the UK’s top academic research centre in the 2008 Higher Education Funding Council Research Assessment Exercise. Based on our publication record, citations and impact we rank among the world’s leading cancer research centres. The Cancer Research UK Cancer Therapeutics Unit (CTU), embedded within the Division of Cancer Therapeutics, is a multidisciplinary 'bench to bedside' centre, comprising around 160 staff dedicated to the discovery and development of novel therapeutics for the treatment of cancer. The Cancer Therapeutics Unit’s exciting goal is to discover high quality drug candidates for validated biological targets and to progress these candidates to clinical trial. All the scientific disciplines are in place to make this possible, including medicinal chemistry, biology, drug metabolism and clinical specialists. A postdoctoral position for a protein crystallographer has become available in Dr Rob van Montfort’s Hit Discovery and Structure-based Design Team within the Cancer Therapeutics Unit (Ref. 1324229) The postdoctoral fellow will be involved in the structure determination of one of our cancer targets and subsequent high-throughput X-ray crystallography, fragment-based screening and structure-based drug design. The successful candidate will interact closely with the biology, computational chemistry and medicinal chemistry teams at the Cancer Therapeutics Unit as well as with the protein crystallographers in the Division of Structural Biology in which the crystallography efforts of Dr van Montfort’s team are embedded. Therefore the successful candidate will be expected to work across the two sites in Chelsea, London and Sutton, Surrey. Applicants must have a PhD in a biological or physical science, and experience in macromolecular crystallography (to include protein biochemistry, protein crystallisation, & protein crystallography). Experience in molecular biology and/or structure-based drug design will be an advantage. The starting salary for the positions will be in the range £28,087 to £38,990 p.a. inclusive (based on previous post-doctoral experience) and the posts are offered on a fixed term contract of 2 years. Informal enquiries to rob.vanmontf...@icr.ac.uk<mailto:rob.vanmontf...@icr.ac.uk> or isaac.westw...@icr.ac.uk<mailto:isaac.westw...@icr.ac.uk>. Please DO NOT send your application to Dr van Montfort or Dr Westwood; applications must be submitted in line with the instructions on our website: http://www.icr.ac.uk<http://www.icr.ac.uk/>. Closing date April 29th 2013.
Dr. Rob van Montfort Team Leader Hit Discovery and Structural Design Sections of Cancer Therapeutics and Structural Biology The Institute of Cancer Research 15 Cotswold Road Sutton SM2 5NG UK Tel: +44-(0)20-8722-4364 (Sutton) +44-(0)20-7153-5142 (Chelsea) Email: rob.vanmontf...@icr.ac.uk<mailto:rob.vanmontf...@icr.ac.uk> The Institute of Cancer Research: Royal Cancer Hospital, a charitable Company Limited by Guarantee, Registered in England under Company No. 534147 with its Registered Office at 123 Old Brompton Road, London SW7 3RP. This e-mail message is confidential and for use by the addressee only. If the message is received by anyone other than the addressee, please return the message to the sender by replying to it and then delete the message from your computer and network.
